SCHEMBL728434

SCHEMBL728434

CCCCC(CC)CN(C=O)CCCC

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
CYP3A4 P08684 6/20 0.45
TSHR P16473 4/20 0.45
TDP1 Q9NUW8 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CA2 P00918 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ATM Q13315 1/20 0.36
MAPK1 P28482 1/20 0.31
PDF Q9HBH1 1/20 0.31
LMNA P02545 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744670 0.93 TSHR (0.42) ALDH1A1CYP3A4TSHRTDP1SMN1; SMN2
SCHEMBL2498047 0.90 ALDH1A1 (0.50) ALDH1A1CYP3A4TSHRTDP1SMN1; SMN2
SCHEMBL10444038 0.84 CYP3A4 (0.41) ALDH1A1CYP3A4TSHRTDP1SMN1; SMN2
SCHEMBL270910 0.78 ADH1C (0.33) TSHRSMN1; SMN2
SCHEMBL26772 0.76 TSHR (0.41) ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL16196082 0.76 LMNA (0.45) TSHRSMN1; SMN2LMNA
SCHEMBL10940372 0.76 TSHR (0.34) TSHRSMN1; SMN2
SCHEMBL6553184 0.76 ALDH1A1 (0.48) ALDH1A1CYP3A4TSHRTDP1SMN1; SMN2
SCHEMBL21431385 0.76 ALDH1A1 (0.34) ALDH1A1CYP3A4TSHRTDP1SMN1; SMN2
SCHEMBL628733 0.75 ALDH1A1 (0.52) ALDH1A1CYP3A4TSHRTDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641828-B Method for separating formic acid from reaction mixture by extraction OXFA有限公司 2022-03-29 CN claimed
EP-3484847-B1 METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION OXFA GMBH (DE) 2020-10-28 EP claimed
EP-3484846-B1 METHOD FOR CATALYTICALLY PRODUCING FORMIC ACID AND REGENERATING THE CATALYST USED IN THE PROCESS WITH LITTLE OVERPRESSURE OXFA GMBH (DE) 2020-09-23 EP claimed
US-10689320-B2 Method for separating formic acid from a reaction mixture by means of extraction OXFA GMBH (DE) 2020-06-23 US claimed
US-20190291093-A1 Method for Catalytically Producing Formic Acid and Regenerating the Catalyst Used in the Process with Little Overpressure OXFA GMBH (DE) 2019-09-26 US claimed
US-20190248727-A1 Method for Separating Formic Acid from a Reaction Mixture by Means of Extraction OXFA GMBH (DE) 2019-08-15 US claimed
EP-3484847-A1 METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION OxFA GmbH (DE) 2019-05-22 EP claimed
EP-3484846-A1 METHOD FOR CATALYTICALLY PRODUCING FORMIC ACID AND REGENERATING THE CATALYST USED IN THE PROCESS WITH LITTLE OVERPRESSURE OxFA GmbH (DE) 2019-05-22 EP claimed
WO-2018015351-A1 METHOD FOR CATALYTICALLY PRODUCING FORMIC ACID AND REGENERATING THE CATALYST USED IN THE PROCESS WITH LITTLE OVERPRESSURE OXFA GMBH (DE) 2018-01-25 WO claimed
WO-2018015352-A1 METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION OXFA GMBH (DE) 2018-01-25 WO claimed
US-20030036664-A1 Waste water treatment in a method for producing formic acid which is free of water BASF AKTIENGESELLSCHAFT (DE) 2003-02-20 US claimed
US-20030009057-A1 Utilization of an extracting agent as antifoaming agent in the production of anhydrous formic acid BASF AKTIENGESELLSCHAFT (DE) 2003-01-09 US claimed
EP-1254099-A2 PROCESS FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-11-06 EP claimed
EP-1250307-A1 UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP claimed
EP-1250305-A2 WASTE WATER TREATMENT IN A METHOD FOR PRODUCING FORMIC ACID WHICH IS FREE OF WATER BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP claimed
EP-1250306-A2 METHOD FOR CLEANING OFF-GAS FLOWS BASF AKTIENGESELLSCHAFT (DE) 2002-10-23 EP claimed
WO-2001055069-A2 WASTE WATER TREATMENT IN A METHOD FOR PRODUCING FORMIC ACID WHICH IS FREE OF WATER BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed
WO-2001055071-A1 UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed
WO-2001055077-A2 FACILITY AND METHOD FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed
WO-2001055070-A2 METHOD FOR CLEANING OFF-GAS FLOWS BASF AKTIENGESELLSCHAFT (DE) 2001-08-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030009057-A1 Utilization of an extracting agent as antifoaming agent in the production of anhydrous formic acid F2, ACSL3, ACSL1 ALDH1A1 463/4885CYP3A4 1558/4885TSHR 4093/4885
US-20030036664-A1 Waste water treatment in a method for producing formic acid which is free of water MGAM, ESD, SMOX ALDH1A1 886/4885CYP3A4 1248/4885TSHR 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.